Akorn Poised For Ch. 11 Sale Following Failed $4.3B Merger
Akorn Inc. said Wednesday it plans to sell all of its assets, potentially seeking Chapter 11 protection, to address litigation costs that have mounted in the wake of the generic-drug maker's...To view the full article, register now.
Already a subscriber? Click here to view full article